Breastfeeding News and Research

Latest Breastfeeding News and Research

Urinary incontinence after child birth increases risk of postpartum depression

Women with urinary incontinence after giving birth are almost twice as likely to develop postpartum depression as those without incontinence, according to a new study led by Wendy Sword, a professor in McMaster University's School of Nursing.

20 Jun 2011

Paternal exposure during pregnancy may affect man's ability to father a child

According to the California Teratogen Information Service (CTIS) Pregnancy Health Information Line, more studies are needed to evaluate men and the potential effect of illnesses, medications and lifestyle habits on fertility and pregnancy. For couples suffering fertility problems, the issue is linked to the potential father approximately 50 percent of the time. In close to a quarter of these cases, a specific cause is unknown.

18 Jun 2011

Poor maternal nutrition predisposes offspring to type 2 diabetes

A new study published by the American Physiological Society offers the strongest evidence yet that vulnerability to type 2 diabetes can begin in the womb, giving new insight into the mechanisms that underlie a potentially devastating disease at the center of a worldwide epidemic.

14 Jun 2011

Eli Lilly, Synthes collaborate to develop osteoinductive products

Synthes, Inc. and Eli Lilly and Company today announced the signing of an exclusive worldwide collaboration agreement to address the needs of patients who are cared for by orthopedic surgeons, including those with osteoporosis and those with bone fractures.

10 Jun 2011

Millennium reports results from two VELCADE based combination studies against multiple myeloma

Millennium: The Takeda Oncology Company with its parent company Takeda Pharmaceutical Company Limited today reported results from two studies of VELCADE (bortezomib) for Injection based combinations in patients with relapsed or refractory multiple myeloma (MM).

8 Jun 2011

Genentech, Astellas announce results of Tarceva Phase III study against advanced NSCLC

Genentech, a member of the Roche Group and Astellas Pharma US, Inc., today announced results of EURTAC, the first Phase III study with Tarceva in Western patients with a genetically distinct type of advanced non-small cell lung cancer (NSCLC).

4 Jun 2011

U of I scientists team up to examine problem of childhood obesity

University of Illinois scientists from a variety of disciplines have teamed up to examine the factors that contribute to childhood obesity. Why? Because individual researchers have found that the problem is too complicated for any of them to tackle alone.

1 Jun 2011

Increase breast feeding rates by extending maternity leave: Study

According to new research published in the journal Pediatrics if the United States wants to significantly increase its breast-feeding rates, extending women's maternity leave would be a good place to start.

31 May 2011

Gerber Products receives first qualified health claim from FDA for infant formulas

Today, Gerber Products Company, a part of the Nestlé family, announced that Gerber Good Start milk-based formulas are the first and only infant formulas that meet the criteria for a qualified health claim.

26 May 2011

Taking prenatal vitamins early during pregnancy can reduce risk of having children with autism

Women who reported not taking a daily prenatal vitamin immediately before and during the first month of pregnancy were nearly twice as likely to have a child with an autism spectrum disorder as women who did take the supplements - and the associated risk rose to seven times as great when combined with a high-risk genetic make-up, a study by researchers at the UC Davis MIND Institute has found.

26 May 2011

Study links early complementary feeding with infant malnutrition in Kenya

A study of infants under 36 months old in a low-income area of Nairobi, Kenya, found that a "lack of information on exclusive breast feeding and low level of education for the mothers is the main cause of the frequent illness and malnutrition among infants," the East African reports.

23 May 2011

Vertex receives FDA approval for INCIVEK to treat hepatitis C

Vertex Pharmaceuticals Incorporated announced that the U.S. Food and Drug Administration (FDA) has approved INCIVEK™ (telaprevir) tablets for a broad group of people with genotype 1 chronic hepatitis C with compensated liver disease (some level of damage to the liver but the liver still functions), including cirrhosis (scarring of the liver).

23 May 2011

Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype 1 infection

Merck, today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has adopted a positive opinion under accelerated assessment recommending approval of the investigational medicine VICTRELIS (boceprevir) for the treatment of chronic hepatitis C virus genotype 1 infection, in combination with peginterferon alfa and ribavirin, in adult patients with compensated liver disease who are previously untreated or who have failed previous therapy.

20 May 2011

$Positive results from Onyx's carfilzomib Phase 2b 003-A1 study in relapsed and refractory multiple myeloma$

Positive results from Onyx's carfilzomib Phase 2b 003-A1 study in relapsed and refractory multiple myeloma

Onyx Pharmaceuticals, Inc. today announced updated results from the Phase 2b 003-A1 study of single-agent carfilzomib, a next generation proteasome inhibitor, in patients with relapsed and refractory multiple myeloma. Carfilzomib achieved a clinical benefit rate (CBR) (minimal response or greater) in the study population of 37 percent with a duration of response (DOR) of 8.3 months.

20 May 2011

Pregnant women warned not to eat for two: Study

According to health experts, there is a “life-long obesity risk of 'eating for two' in pregnancy”. The common advice is reinforced by the results of a study that followed women for a number of years.

19 May 2011

New data on personalized approaches for skin, ovarian and lung cancer to be presented at ASCO meeting

Genentech, a member of the Roche Group, today announced that data showing new personalized approaches for people with skin and lung cancer, plus new data with Avastin in ovarian cancer, will be presented at the 47th Annual Meeting of the American Society of Clinical Oncology.

18 May 2011

Eli Lilly responds to Amylin's exenatide lawsuit

Eli Lilly and Company has provided additional perspective in response to Amylin Pharmaceuticals, Inc.'s lawsuit filed in the United States District Court for the Southern District of California.

17 May 2011

Breastfeeding leads to better behaviour in kids: Study

A new study shows that just four months of breastfeeding can cut the risk of children becoming badly behaved by almost a third. It found 16 per cent of children brought up on formula milk had problems including anxiety, lying, stealing and hyperactivity – more than double the proportion breastfed for at least four months.

10 May 2011

Study analyzes breast-feeding frequency of infants in eight inner-city Philadelphia health centers

"Breastfeeding is a hot topic. We know it is beneficial for most babies and that many are not getting breastfed," said lead study author Jessica Robbins, Ph.D., a public health epidemiologist with the Philadelphia Department of Public Health.

7 May 2011

Millennium presents VELCADE Phase III trial data in multiple myeloma at IMW meeting

Millennium: The Takeda Oncology Company today reported the presentation of results of a randomized Phase III trial that investigated the effect of consolidation with single-agent VELCADE for Injection in newly diagnosed multiple myeloma patients after autologous stem cell transplant.

7 May 2011

Breastfeeding News and Research

Latest Breastfeeding News and Research

Urinary incontinence after child birth increases risk of postpartum depression

Paternal exposure during pregnancy may affect man's ability to father a child

Poor maternal nutrition predisposes offspring to type 2 diabetes

Eli Lilly, Synthes collaborate to develop osteoinductive products

Millennium reports results from two VELCADE based combination studies against multiple myeloma

Genentech, Astellas announce results of Tarceva Phase III study against advanced NSCLC

U of I scientists team up to examine problem of childhood obesity

Increase breast feeding rates by extending maternity leave: Study

Gerber Products receives first qualified health claim from FDA for infant formulas

Taking prenatal vitamins early during pregnancy can reduce risk of having children with autism

Study links early complementary feeding with infant malnutrition in Kenya

Vertex receives FDA approval for INCIVEK to treat hepatitis C

Merck's VICTRELIS receives European CHMP positive opinion for treatment of chronic HCV genotype 1 infection

Positive results from Onyx's carfilzomib Phase 2b 003-A1 study in relapsed and refractory multiple myeloma

Pregnant women warned not to eat for two: Study

New data on personalized approaches for skin, ovarian and lung cancer to be presented at ASCO meeting

Eli Lilly responds to Amylin's exenatide lawsuit

Breastfeeding leads to better behaviour in kids: Study

Study analyzes breast-feeding frequency of infants in eight inner-city Philadelphia health centers

Millennium presents VELCADE Phase III trial data in multiple myeloma at IMW meeting

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Breastfeeding News and Research

Latest Breastfeeding News and Research

Leveraging the Radian ASAP in standard casework

A journey through science, software, and innovation: Insights from the Bruker software team

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Newsletters you may be interested in